Tag results:

myeloid cells

Trastuzumab/Pertuzumab Combination Therapy Stimulates Anti-tumor Responses through Complement-Dependent Cytotoxicity and Phagocytosis

[JCI Insight] Investigators identified that only Trastuzumab+Pertuzumab combination therapy, but not when either antibody used in isolation, allowed for the activation of the classical complement pathway, resulting in both direct complement-dependent cytotoxicity as well as complement-dependent cellular phagocytosis of HER2+ breast cancer cells.

Mapping the Biogenesis of Forward Programmed Megakaryocytes from Induced Pluripotent Stem Cells

[Science Advances] Investigators developed a system for the production of platelet precursor cells, megakaryocytes, from PSCs. These cultures could be maintained for greater than 100 days, implying culture renewal by megakaryocyte progenitors.

PD-L1 Blockade Liberates Intrinsic Antitumourigenic Properties of Glycolytic Macrophages in Hepatocellular Carcinoma

[Gut] Scientists elucidated the nature, regulation and functional relevance of PD-L1+ host cells in HCC.

Increased Visceral Fat Distribution and Body Composition Impact Cytokine Release Syndrome Onset and Severity after CD19 CAR-T in Advanced B Cell Malignancies

[Haematologica] Researchers studied the influence of anthropometric and body composition measurements on CAR-T-related immunotoxicity in 64 patients receiving CD19-directed CAR-T for relapsed/refractory B cell malignancies.

Neutrophil-Derived Extracellular Vesicles Promote Feed-Forward Inflammasome Signaling in Cystic Fibrosis Airways

[Journal of Leukocyte Biology] Researchers hypothesized that cystic fibrosis airway neutrophils contributed to chronic inflammation, in part, via the packaging of inflammasome-inducing signals in extracellular vesicles.

Dual-sgRNA CRISPR/Cas9 Knockout of PD-L1 in Human U87 Glioblastoma Tumor Cells Inhibits Proliferation, Invasion, and Tumor-Associated Macrophage Polarization

[Scientific Reports] Utilizing dual-single guide RNAs (sgRNAs) and a homology-directed repair template with the CRISPR/Cas9 gene-editing system is a promising avenue for the treatment of glioblastoma multiforme.

Popular